Robeco Institutional Asset Management B.V. Sells 118,233 Shares of Docusign Inc. $DOCU

Key Points

• Robeco Institutional Asset Management B.V. sold 118,233 shares of Docusign Inc., reducing its stake by 24.1% to a total of 372,487 shares valued at approximately $29 million.
• Several brokerages have recently updated their price targets for Docusign, with consensus ranging from $85.00 to $95.00, indicating mixed sentiment about the stock's performance.
• Docusign reported a quarterly EPS of $0.92, surpassing expectations of $0.84, alongside an increase in revenue by 8.8% year-over-year to $800.64 million.

Robeco Institutional Asset Management B.V. decreased its position in shares of Docusign Inc. (NASDAQ:DOCU - Free Report) by 24.1% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 372,487 shares of the company's stock after selling 118,233 shares during the quarter. Robeco Institutional Asset Management B.V. owned about 0.18% of Docusign worth $29,013,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Hemington Wealth Management increased its holdings in shares of Docusign by 318.1% during the first quarter. Hemington Wealth Management now owns 347 shares of the company's stock valued at $28,000 after acquiring an additional 264 shares in the last quarter. Banque Transatlantique SA bought a new stake in Docusign during the first quarter worth $26,000. Golden State Wealth Management LLC grew its holdings in Docusign by 519.4% during the first quarter. Golden State Wealth Management LLC now owns 384 shares of the company's stock worth $31,000 after buying an additional 322 shares in the last quarter. Summit Securities Group LLC bought a new stake in Docusign during the first quarter worth $34,000. Finally, Rise Advisors LLC grew its holdings in Docusign by 864.6% during the first quarter. Rise Advisors LLC now owns 463 shares of the company's stock worth $38,000 after buying an additional 415 shares in the last quarter. Institutional investors own 77.64% of the company's stock.

Analysts Set New Price Targets

Several brokerages recently issued reports on DOCU. Wedbush decreased their price target on Docusign from $100.00 to $85.00 and set a "neutral" rating for the company in a report on Thursday, June 12th. Royal Bank Of Canada upped their price target on Docusign from $90.00 to $95.00 and gave the stock a "sector perform" rating in a report on Friday, September 5th. UBS Group set a $95.00 price target on Docusign in a report on Friday, September 5th. Morgan Stanley upped their price objective on Docusign from $86.00 to $90.00 and gave the company an "equal weight" rating in a research note on Monday, September 8th. Finally, Needham & Company LLC restated a "hold" rating on shares of Docusign in a research note on Friday, September 5th. One analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and fifteen have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average price target of $94.14.

Docusign Price Performance

Shares of NASDAQ DOCU opened at $69.73 on Friday. Docusign Inc. has a one year low of $62.66 and a one year high of $107.86. The business's fifty day moving average price is $76.17 and its 200-day moving average price is $79.09. The stock has a market capitalization of $14.02 billion, a PE ratio of 52.43, a P/E/G ratio of 3.39 and a beta of 1.02.

Docusign (NASDAQ:DOCU - Get Free Report) last issued its quarterly earnings results on Thursday, September 4th. The company reported $0.92 EPS for the quarter, beating analysts' consensus estimates of $0.84 by $0.08. Docusign had a return on equity of 14.01% and a net margin of 9.08%.The firm had revenue of $800.64 million for the quarter, compared to analysts' expectations of $780.35 million. During the same quarter in the prior year, the firm earned $0.97 EPS. The business's revenue for the quarter was up 8.8% compared to the same quarter last year. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. As a group, equities analysts expect that Docusign Inc. will post 1.17 EPS for the current fiscal year.

Insider Activity

In other news, CEO Allan C. Thygesen sold 40,000 shares of the company's stock in a transaction on Wednesday, October 1st. The stock was sold at an average price of $69.69, for a total transaction of $2,787,600.00. Following the transaction, the chief executive officer owned 136,246 shares of the company's stock, valued at $9,494,983.74. This represents a 22.70% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider James P. Shaughnessy sold 7,500 shares of the stock in a transaction dated Wednesday, October 1st. The stock was sold at an average price of $71.19, for a total value of $533,925.00. Following the sale, the insider directly owned 55,442 shares in the company, valued at $3,946,915.98. This trade represents a 11.92% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 96,533 shares of company stock worth $7,281,953. 1.01% of the stock is owned by company insiders.

Docusign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.